Please find attached Briefing Paper

Why is it of importance to Government, the National Health Service, and medical device companies to consider new developments in antimicrobial surfaces?

• Conventional approaches are not sufficient to tackle biofilms and surface attached cells.
• Developing effective, low-cost strategies to fight HCAI and AMR is a key target for government and health service providers.
• Minimising health and safety risks.
• Regulatory Changes. Concerns about environmental pollution and toxicity are leading to regulatory changes, limiting the use of previously widely employed solutions
• Greener product formulations for biofilm control.

Attached Images
Last edited by Alf; 12/08/24 6:57 PM.

Darren Magee
International Advisor, Consultant & Subject Matter Expert - STEM Ambassador - EBME/MPCE/Decontamination - Medical Device Designer - Environment Solution